U.S. Stem Cell
U.S. Stem Cell, based in Sunrise, US, offers innovative regenerative and cellular therapies for degenerative conditions.
Founded
1999U.S. Stem Cell, based in Sunrise, US, offers innovative regenerative and cellular therapies for degenerative conditions.
U.S. Stem Cell, headquartered in Sunrise, US, is dedicated to advancing regenerative medicine and autologous cellular therapies for treating degenerative conditions. The company focuses on pioneering research and development in stem cell treatments, offering innovative protocols and products designed to improve patient outcomes. Additionally, U.S. Stem Cell provides accredited training programs to physicians globally, ensuring the widespread adoption and implementation of regenerative medicine techniques.
Notable figures affiliated with U.S. Stem Cell include leading researchers and medical professionals in the field of regenerative medicine. The company has achieved significant milestones in developing new applications for various diseases and maintaining the largest network of trained physicians in regenerative medicine worldwide. Through its groundbreaking work, U.S. Stem Cell has made a substantial impact on the treatment landscape for degenerative conditions, contributing to the advancement of medical science and patient care.
Companies similar to U.S. Stem Cell include Cellebration Life Sciences, LaCell, Celularity and Athersys.
U.S. Stem Cell was founded in 1999.
U.S. Stem Cell's headquarters is located in Sunrise, FL, US.
U.S. Stem Cell's most recent funding round was for $190k (USD) in February 2021.
As of Feb 22, 2021, U.S. Stem Cell has disclosed funding of $897k (USD). Undisclosed round amounts are excluded.
U.S. Stem Cell has 7 employees as of Feb 5, 2024.
